These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 915914)

  • 1. Isoquinolines. 6. Potential central nervous system antitumor agents. Nitrogen mustards of 3-amino-4-(p-aminophenyl)isoquinoline.
    Filer CN; Granchelli FE; Soloway AH; Neumeyer JL
    J Med Chem; 1977 Nov; 20(11):1504-8. PubMed ID: 915914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aporphines. 31. Synthesis and antitumor activity of aporphine nitrogen mustards.
    Neumeyer JL; Granchelli FE; Filer CN; Soloway AH; Law SJ
    J Med Chem; 1980 Sep; 23(9):1008-13. PubMed ID: 7411543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and anticancer activity of 5-diethylaminomethyl derivatives and nitrogen mustards of uracil and 2-thiouracils.
    Fabrissin S; de Nardo M; Nisi C; Morasca L; Dolfini E; Franchi G
    J Med Chem; 1976 May; 19(5):639-42. PubMed ID: 1271405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor and mutagenic properties of a variety of heterocyclic nitrogen and sulfur mustards.
    Creech HJ; Preston RK; Peck RM; O'Connell AP
    J Med Chem; 1972 Jul; 15(7):739-46. PubMed ID: 4557857
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential central nervous system antitumor agents. Hydantoin derivatives.
    Peng GW; Marquez VE; Driscoll JS
    J Med Chem; 1975 Aug; 18(8):846-9. PubMed ID: 1159704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antitumor evaluation of some nitrosourea and nitrogen mustard amino acid derivatives.
    Rodriguez M; Imbach JL; Martinez J
    J Med Chem; 1984 Sep; 27(9):1222-5. PubMed ID: 6471076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-(2-chloroethyl)-N-(2-hydroxyethyl)arylamines. Possible intermediates to potential carcinolytic agents bearing dissimilar reactive functions.
    Foster AB; Jarman M; Ross WC; Tisdale MJ
    J Med Chem; 1972 Aug; 15(8):869-70. PubMed ID: 5044312
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential antitumor agents: steroidal amidoesters with an alkylating moiety.
    Papageorgiou A; Boutis L; Nicolaropoulos S; Catsoulacos P
    Oncology; 1987; 44(2):128-32. PubMed ID: 3574853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential antitumor agent dicyclohexylammonium 2-(4-N,N-bis(2-chloroethyl) amino)phenoxy)-2-methylpropionate.
    Sommer HZ; Wicks GE
    J Med Chem; 1972 Apr; 15(4):436-7. PubMed ID: 5019572
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of naphthalmustine, a nitrogen mustard derivative of naphthalimide as a rationally-designed anticancer agent.
    Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Qazi GN; Sanyal U
    J Exp Clin Cancer Res; 2003 Sep; 22(3):411-8. PubMed ID: 14582700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new steroidal alkylating agent with improved activity in advanced murine leukemias.
    Catsoulacos P; Politis D; Wampler GL
    Cancer Chemother Pharmacol; 1979; 3(1):67-70. PubMed ID: 535128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of 4-(p-(bis(2-chloroethyl)amino)phenyl)butyramides as potential antitumor agents. I.
    Billman JH; Roehrig GR
    J Pharm Sci; 1974 Sep; 63(9):1487-9. PubMed ID: 4427280
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential anticancer agents. 4. Schiff bases from benzaldehyde nitrogen mustards.
    Shekawat DR; Sabnis SS; Deliwala CV
    J Med Chem; 1972 Nov; 15(11):1196-7. PubMed ID: 4654676
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and evaluation of antitumor activity of 1-[N, N-bis(2-chloroethyl) sulfamoylphenyl]-3,3-dialkyltriazenes.
    Lalezari I; Afghahi F
    J Pharm Sci; 1975 Apr; 64(4):698-9. PubMed ID: 1142087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential anticancer agents. Nitrogen mustards of aminophenylthiazoles.
    Modi JD; Sabnis SS; Deliwala CV
    J Med Chem; 1971 Sep; 14(9):887-8. PubMed ID: 5140020
    [No Abstract]   [Full Text] [Related]  

  • 16. Selective cytotoxicity of a system L specific amino acid nitrogen mustard.
    Haines DR; Fuller RW; Ahmad S; Vistica DT; Marquez VE
    J Med Chem; 1987 Mar; 30(3):542-7. PubMed ID: 3820226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and anti-tumour activity of the spatially-separated mustard bis-N,N'-[3-(N-(2-chloroethyl)-N-ethyl)amino-5-[N,N-dimethylamino)methy l)-aminophenyl]-1,4-benzenedicarboxamide, which alkylates DNA exclusively at adenines in the minor groove.
    Prakash AS; Valu KK; Wakelin LP; Woodgate PD; Denny WA
    Anticancer Drug Des; 1991 Jul; 6(3):195-206. PubMed ID: 1872947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of pre-activated analogs of cyclophosphamide (NSC-26271).
    Montgomery JA; Struck RF
    Cancer Treat Rep; 1976 Apr; 60(4):381-93. PubMed ID: 945126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of current alkylating agents with a homo-aza-steroidal ester for antineoplastic activity.
    Catsoulacos P; Papageorgiou A; Margarity E; Mourelatos D; Mioglou E
    Oncology; 1994; 51(1):74-8. PubMed ID: 8265107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-directed alkylating agents. 1. Structure-activity relationships for acridine-linked aniline mustards: consequences of varying the reactivity of the mustard.
    Gourdie TA; Valu KK; Gravatt GL; Boritzki TJ; Baguley BC; Wakelin LP; Wilson WR; Woodgate PD; Denny WA
    J Med Chem; 1990 Apr; 33(4):1177-86. PubMed ID: 2319563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.